Eos logo

Eos

Europe, Fife, United Kingdom, Saint Andrews

Description

Eos is focused on providing seed funding to ventures based upon strong and innovative science, technology and engineering.

Investor Profile

Eos has made 27 investments, with 6 in the past 12 months and 52% as lead.

Stage Focus

  • Seed (74%)
  • Series A (11%)
  • Series Unknown (11%)
  • Private Equity (4%)

Country Focus

  • United Kingdom (96%)
  • Ireland (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Manufacturing
  • Health Diagnostics
  • Machine Learning
  • Oncology
  • Oil And Gas
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eos frequently co-invest with?

MV
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 2
Maven Capital Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 5
SV
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 6
AE
Europe, Aberdeen City, United Kingdom, Aberdeen
Co-Investments: 3
Kelvin Capital
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
Scottish Investment Bank
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
University of Strathclyde
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 4
Old College Capital
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 5
NC
Europe, East Sussex, United Kingdom, Wadhurst
Co-Investments: 3
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 12

Which angels does Eos often collaborate with?

MB
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Eos?

Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
Series UnknownFeb 3, 2025
Amount Raised: $6,200,000
Concinnity Genetics

Edinburgh, Edinburgh, City of, United Kingdom

Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.

BiotechnologyGeneticsTherapeutics
SeedDec 16, 2024
Amount Raised: $3,806,865
Biotangents

Penicuik, Midlothian, United Kingdom

Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.

BiotechnologyChemicalMedical DeviceVeterinary
Series UnknownNov 28, 2024
Amount Raised: $2,920,023
Naturbeads

Bath, Bath and North East Somerset, United Kingdom

Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products

Advanced MaterialsBiotechnologyCleanTechManufacturing
Series ANov 14, 2024
Amount Raised: $9,878,269
Chromacity

Edinburgh, Edinburgh, City of, United Kingdom

Chromacity Lasers is a spin-out from Heriot-Watt University, one of the UK’s leading technical universities with a focus on photonics.

Information TechnologySemiconductor
SeedJul 31, 2024
Amount Raised: $1,284,406
Nami Surgical

Glasgow, Glasgow City, United Kingdom

Nami Surgical offers robotic surgery technology solutions to improve patient care.

Health CareManufacturingRobotics
SeedMay 8, 2024
Amount Raised: $3,123,298
Neupulse

Nottingham, Nottingham, United Kingdom

Neupulse provides healthcare services.

Health CareHospital
SeedMar 18, 2024
Amount Raised: $3,200,000
Wobble Genomics

Edinburgh, Edinburgh, City of, United Kingdom

Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

Biotechnology
SeedMar 7, 2024
Amount Raised: $10,891,348
Carcinotech

Edinburgh, Edinburgh, City of, United Kingdom

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours for cancer research

BiotechnologyLife ScienceMedicalOncology
SeedJan 29, 2024
Amount Raised: $5,339,877
Cumulus Oncology

Edinburgh, Edinburgh, City of, United Kingdom

Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.

BiotechnologyHealth CareOncologyPharmaceutical
SeedJan 8, 2024
Amount Raised: $11,467,685